Research on chemotherapy-induced nausea: back to the past for an unmet need?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
   Trial
2. Cheaper Options in the Prevention of Chemotherapy-Induced Nausea and Vomiting.Journal of global oncology · 2016
   Review
3. Defining optimal control of chemotherapy-induced nausea and vomiting-based on patients' experience.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2015
   Article

Corrections and comments

• Commented on by
  Reply to L. Celio et al and H. Ishiguro et al.2013
• Comment on
  Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy.2012

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as